Weaknesses in the reporting of cross-sectional studies according to the STROBE statement the case of metabolic syndrome in adults from Peru
Article Sidebar
Main Article Content
Introduction:
The inadequate reporting of cross-sectional studies, as in the case of the prevalence of metabolic syndrome, could cause problems in the synthesis of new evidence and lead to errors in the formulation of public policies.
Objective:
To evaluate the reporting quality of the articles regarding metabolic syndrome prevalence in Peruvian adults using the STROBE recommendations.
Methods:
We conducted a thorough literature search with the terms "Metabolic Syndrome", "Sindrome Metabolico" and "Peru" in MEDLINE/PubMed, LILACS, SciELO, LIPECS and BVS-Peru until December 2014. We selected those who were population-based observational studies with randomized sampling that reported prevalence of metabolic syndrome in adults aged 18 or more of both sexes. Information was analysed through the STROBE score per item and recommendation.
Results:
Seventeen articles were included in this study. All articles met the recommendations related to the report of the study's rationale, design, and provision of summary measures. The recommendations with the lowest scores were those related to the sensitivity analysis (8%, n= 1/17), participant flowchart (18%, n= 3/17), missing data analysis (24%, n= 4/17), and number of participants in each study phase (24%, n= 4/17).
Lang T, Secic M. How to report statistics in medicine. Philadelphia: American College of Physicians; 2006.
Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–276.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):296–296.
Mannocci A, Saulle R, Colamesta V, D'Aguanno S, Giraldi G, Maffongelli E, et al. What is the impact of reporting guidelines on Public Health journals in Europe? The case of STROBE, CONSORT and PRISMA. J Public Health (Oxf) 2015;37(4):737–740.
Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):297–297.
da Costa BR, Cevallos M, Altman DG, Rutjes AWS, Egger M. Uses and misuses of the STROBE statement: bibliographic study. BMJ Open. 2011;1(1):000048–000048.
Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–689.
Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease. Diabetes Care. 2004;27(11):2676–2681.
Reaven GM. The metabolic syndrome: time to get off the merry-go-round? J Intern Med. 2011;269(2):127–136.
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607.
Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–131.
Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752.
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–480.
Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, American Heart Association et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–438.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Loannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):1000100–1000100.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. Declaración de la Iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionales. Gac Sanit. 2008;22(2):144–150.
Soto V, Vergara E, Neciosup E. Prevalencia y factores de riesgo de síndrome metabólico en población adulta del Departamento de Lambayeque, Perú - 2004. Rev Peru Med Exp Salud Publica. 2005;22(4):254–261.
Guarnizo PM, Loayza RG, Calvay SM, Ynami-Vizcaya M, Lázaro AH. Síndrome metabólico en una población pesquera y otra agropecuaria de la costa del Perú Rev Soc Per Med Inter. 2006;29(3):685–691.
Lorenzo C, Serrano-Ríos M, Martínez-Larrad MT, González-Sánchez JL, Seclén S, Villena A, et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care. 2006;29(3):685–691.
Seclén S, Villena A, Larrad MT, Gamarra D, Herrera B, Pérez CF, et al. Prevalence of the metabolic syndrome in the mestizo population of Peru. Metab Syndr Relat Disord. 2006;4(1):1–6.
Pajuelo J, Sánchez J. El síndrome metabólico en adultos, en el Perú An Fac Med. 2007;68(1):38–46.
Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, Bolaños-Salazar JF, Muñoz-Atahualpa E, Postigo-MacDowall M, et al. Prevalence of the metabolic syndrome in Peruvian Andean hispanics: the PREVENCION study. Diabetes Res Clin Pract. 2007;78(2):270–281.
Baracco R, Mohanna S, Seclén S. A comparison of the prevalence of metabolic syndrome and its components in high and low altitude populations in peru. Metab Syndr Relat Disord. 2007;5(1):55–62.
Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121(1):58–65.
Cárdenas QH, Sánchez AJ, Roldán AL, Mendoza TF. Prevalencia del síndrome metabólico en personas a partir de 20 años de edad. Perú, 2005. Rev Esp Salud Publica. 2009;83(2):257–265.
Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, et al. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009;8:52–52.
Gelaye B, Revilla L, Lopez T, Sanchez S, Williams MA. Prevalence of metabolic syndrome and its relationship with leisure time physical activity among Peruvian adults. Eur J Clin Invest. 2009;39(10):891–898.
Masterson CRM, Smeeth L, Gilman RH, Miranda JJ. Physical activity and cardiovascular risk factors among rural and urban groups and rural-to-urban migrants in Peru: a cross-sectional study. Rev Panam Salud Publica. 2010;28(1):1–8.
Medina-Lezama J, Pastorius CA, Zea-Diaz H, Bernabe-Ortiz A, Corrales-Medina F, Morey-Vargas OL, et al. Optimal definitions for abdominal obesity and the metabolic syndrome in Andean Hispanics: the PREVENCION study. Diabetes Care. 2010;33(6):1385–1388.
Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart. 2011;97(10):787–796.
Boissonnet C, Schargrodsky H, Pellegrini F, Macchia A, Marcet CB, Wilson E, et al. Educational inequalities in obesity, abdominal obesity, and metabolic syndrome in seven Latin American cities: the CARMELA Study. Eur J Cardiovasc Prev Rehabil. 2011;18(4):550–556.
Pajuelo J, Sánchez-Abanto J, Torres H, Miranda M. Prevalencia del síndrome metabólico en pobladores peruanos por debajo de 1000 y por encima de los 3000 msnm. An Fac Med. 2012;73(2):101–106.
Bernabe-Ortiz A, Benziger CP, Gilman RH, Smeeth L, Miranda JJ. Sex differences in risk factors for cardiovascular disease: the PERU MIGRANT study. PLoS One. 2012;7(4):35127–35127.
Instituto Nacional de Salud del Perú . Encuesta Nacional de Indicadores Nutricionales, Bioquímicos, Socioeconómicos y Culturales relacionados con las enfermedades crónicas degenerativas. Ministerio de Salud del Peru; 2006. [31 12 2014]. Available from: http://www.minsa.gob.pe/portada/Especiales/2007/nutricion/publicaciones/INFORME_FINAL_ENIN.pdf.
Miranda JJ, Gilman RH, García HH, Smeeth L. The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study. BMC Cardiovasc Disord. 2009;9:23–23.
Medina-Lezama J, Chirinos JA, Zea Díaz H, Morey O, Bolanos JF, Munoz-Atahualpa E, et al. Design of PREVENCION: a population-based study of cardiovascular disease in Peru. Int J Cardiol. 2005;105(2):198–202.
Egger M, Altman DG, Vandenbroucke JP, of the STROBE group Commentary: strengthening the reporting of observational epidemiology the STROBE statement. Int J Epidemiol. 2007;36(5):948–950.
Fung AE, Palanki R, Bakri SJ, Depperschmidt E, Gibson A. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies. Ophthalmology. 2009;116(2):286–296. [PubMed]
Müller M, Egger M. Strengthening the reporting of observational epidemiology (STROBE) in sexual health. Sex Transm Infect. 2009;85(3):162–164. [PubMed]
Papathanasiou AA, Zintzaras E. Assessing the quality of reporting of observational studies in cancer. Ann Epidemiol. 2010;20(1):67–73.
Galera LJ, Lahoz GR, Roig LF. Comunicación de los resultados de la investigación observacional: análisis mediante la guía Strobe. Rev Esp Salud Publica. 2011;85(6):583–591.
Bastuji-Garin S, Sbidian E, Gaudy-Marqueste C, Ferrat E, Roujeau J-C, Richard M-A, et al. Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis. PLoS One. 2013;8(8):64733–64733.
Jeelani A, Malik W, Haq I, Aleem S, Mujtaba M, Syed N. Cross-sectional studies published in Indian journal of community medicine: evaluation of adherence to strengthening the reporting of observational studies in epidemiology statement. Ann Med Health Sci Res. 2014;4(6):875–878.
Pouwels KB, Widyakusuma NN, Groenwold RH, Hak E. Quality of reporting of confounding remained suboptimal after the STROBE guideline. J Clin Epidemiol. 2015 Epub ahead of print.
Glujovsky D, Villanueva E, Reveiz L, Murasaki R. Adherencia a las guías de informe sobre investigaciones en revistas biomédicas en América Latina y el Caribe. Rev Panam Salud Publica. 2014;36(4):232–237.
Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ. 2012;344:4178–4178.
Popham K, Calo WA, Carpentier MY, Chen NE, Kamrudin SA, Le YC, et al. Reporting guidelines: optimal use in preventive medicine and public health. Am J Prev Med. 2012;43(4):31–42.
Downloads
Accepted 2015-09-22
Published 2015-12-30
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use